
Intercept Pharmaceuticals sale carries big risk
Published 4:31 pm, Tuesday, February 16, 2016
Nice article but a simple check would help to replace the nonalcoholic stearoarthritis mentionned in the text by the nonalcoholic steatohepatitis
An overview on NASH disease
and future treatments
PHASE III ‘REGENERATE’ RECRUITMENT !
A REASON OF HOURS ?
INTERCEPT PHARMACEUTICAL PBC AND FDA ?
THE FUTURE OF INTERCEPT PHARMACEUTICAL IN NASH ?
THE NEW DEFINITION OF NASH STRIKE THE NASH PLAYERS
A FIRST ANALYSIS ON THE INTERCEPT PHASE 2 ON NASH IN JAPAN
INTERCEPT: WHAT WE LEARN FROM OCA'S FAILURE IN JAPAN PHASE 2 NASH TRIAL
This publication reflects the views only of the authors, and he cannot be held responsible for any use which may be made of the information contained therein. The authors of the articles published here are not physician, financial analysts or market professionals. announced data may contain errors, inaccuracies and misinterpretations of facts.The authors could have their own stoks positions on these values. it is therefore recommended to the reader to verify the facts, to inform himself before any investment on listed companies and to make decisions based on his own judgment. The informations and reflections that can be found on this website are by no means of incentives for the purchase or sale of listed securities but personal opinions of the authors, which does not represent the point of view of the mentionned companies
The main author is not english language native so you can find some gramatical errors or misspelling in the english translated articles. If you have time you can send corrections to author or better, you can propose a full article correction.
Positions of G.Divry on the biotech’s mentioned in articles:
GENFIT : H1 2013 - to date: Long
CONATUS : to date: No Position
GALT : Jan 2018 - to date: Long
MDGL : to date : No Position
Intercept Pharmaceuticals sale carries big risk
Published 4:31 pm, Tuesday, February 16, 2016
Nice article but a simple check would help to replace the nonalcoholic stearoarthritis mentionned in the text by the nonalcoholic steatohepatitis